Microbot Medical, Inc. (MBOT) - Cumulative Company Assets

Public company logo of Microbot Medical, Inc. (MBOT)

Microbot Medical Inc. (MBOT) utilizes contract manufacturing for components of its microrobots developed in US and Israeli laboratories, as confirmed by the price chart on GURU.Markets, where total assets amount to 53.26. The business's environmental focus is reflected in the minimization of medical waste through precision navigation. However, potential funding gaps and prolonged FDA reviews of the Liberty system remain significant burdens.

Microbot Medical, Inc. (MBOT) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for Microbot Medical Inc (MBOT)

- price and consensus price forecast:
Price microbotmedical.com|MBOT - Price Target Chart
- market capitalization data:
Market Valuation Microbot Medical, Inc|MBOT - Enterprise Value
- book capitalization data:
Net Asset Value per Share Microbot Medical|MBOT - Book Capitalization|Capitalization to Book Value Ratio microbotmedical.com|MBOT - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Microbot Medical Inc.|MBOT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Microbot Medical, Inc|MBOT - Company Aggregate Debts|Debts to Book Capitalization Microbot Medical, Inc
Fundamental valuation:microbotmedical.com, MBOT
Manufactured product of Microbot Medical Inc.

This metric aggregates the total value of all Microbot Medical Inc. (MBOT) resources, calculated inversely through daily return on assets. Analyzing the total asset value reveals a critical gap between market capitalization and the actual tangible basis. The trend of this indicator serves as a signal for potential price corrections during periods of overvalued quotes. The stability of the base is maintained by retaining a unique staff of microsurgery robotics engineers.

Main competitors

ISRG (intuitive.com) - Aggregate Business Assets|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|MMSI (Merit Medical Systems Inc) - Company Total Assets|Nobel Biocare (NVST) - Cumulative Company Assets|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets XRAY|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets AtriCure Inc ATRC|Cumulative Company Assets STAAR Surgical Corp|Aggregate Asset Value ChromaDex NAGE|Company Total Assets ZIMV (ZimVie Inc.)|ANGO: Company Total Asset Base|Aggregate Company Assets Cerus|TKNO (Alpha Teknova) - Total Business Assets|MGRM: Aggregate Company Assets|Company Total Asset Base Sharps Tech (STSS)|Cumulative Company Assets InfuSystem Holdings|Aggregate Business Assets UTMD (utahmed.com)|Aggregate Company Assets KORU Medical|NYXH - Aggregate Asset Value|Pro-Dex Corp - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|NURO (NeuroMetrix Corp) - Aggregate Company Assets